Flash FinanceUS
Pre-market S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Hims & Hers Health (HIMS)

Hims & Hers Q4 revenue rises 28% to $617.8 million; net income falls to $20.6 million

Mixed Impact 3 of 5 earnings Written later

Hims & Hers reported fourth-quarter and full-year 2025 results, with revenue up 59% for the year to $2.35 billion and full-year net income of $128.4 million. Fourth-quarter net income fell from $26.0 million a year earlier, and gross margin dropped to 72% from 77%. The company guided to 2026 revenue of $2.7 billion to $2.9 billion and Adjusted EBITDA of $300 million to $375 million, excluding the proposed Eucalyptus acquisition.

Key points

  • Q4 2025 revenue was $617.8 million, up 28% from $481.1 million; full-year revenue was $2.35 billion, up 59%.
  • Q4 2025 net income was $20.6 million versus $26.0 million in Q4 2024; full-year net income was $128.4 million versus $126.0 million.
  • Full-year 2025 Adjusted EBITDA was $318.0 million versus $176.9 million in 2024; Q4 free cash flow was $(2.6) million versus $59.5 million.
  • 2026 guidance: first-quarter revenue of $600 million to $625 million and full-year revenue of $2.7 billion to $2.9 billion; guidance excludes the proposed Eucalyptus acquisition, expected to close mid-2026.

The filing

CompanyHims & Hers Health (HIMS)
Form8-K, current report
Filed with the SECFeb 23, 2026, 4:07 PM ET
Accession number0001773751-26-000019

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 12:59 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on February 23, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.